Clinical Trial Update: Efficacy/Safety Study of R-CHOP vs Bortezomib-R-CAP for Young Patients With Diffuse Large B-cell Lymphoma With Poor IPI. [Phase 2]

View source ↗

Summary

Phase 2 trial comparing R-CHOP to Bortezomib-R-CAP in young patients with diffuse large B-cell lymphoma and poor IPI; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Bortezomib-R-CAP
• R-CHOP

Snippet

Sponsor: Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | Conditions: Diffuse, Large B-Cell, Lymphoma | Phase 2 | Status: COMPLETED